1-3 of 3
Ying Lin
Close
Sort by
Journal Articles

Clinicopathologic Features and Outcome of Chinese Patients with Myelofibrosis

Harinder Gill, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Yu Yan Hwang, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Thomas Sau Yan Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Chi Chung Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Candia Hay Nun Chan, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Herman S.Y. Liu, MD, Vivien Mak, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Shek Ying Lin, MBBS, MRCP (UK), FHKCP, FHKAM (MDcine), Chi Kuen Lau, MD, Anskar Y.H. Leung, MD, Albert Kwok Wai Lie, MD, Yok Lam Kwong, MD
Journal: Blood
Blood (2014) 124 (21): 3174.
https://doi.org/10.1182/blood.V124.21.3174.3174
Published: 2014
Journal Articles

Oral arsenic trioxide–based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study

Clinical Trials & Observations
Wing-Yan Au, Cyrus R. Kumana, Harold K. K. Lee, Shek-Ying Lin, Herman Liu, Dominic Y. M. Yeung, June S. M. Lau, Yok-Lam Kwong
Journal: Blood
Blood (2011) 118 (25): 6535–6543.
https://doi.org/10.1182/blood-2011-05-354530
Published: 2011
Journal Articles

Combinations of Epigenetic Modifying Agents Accentuate Retinoid-Mediated Gene Expression Over Single Agent Therapies In Acute Myelogenous Leukemia Cells

Michael Trus, MD, PhD, FRCPC, Ying Lin, Gurmit Singh, PhD, Mark D. Minden, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2497.
https://doi.org/10.1182/blood.V116.21.2497.2497
Published: 2010